Climatic and Geographic Variations of Antecedent Infections in Guillain–Barré Syndrome: A Long‐Term Longitudinal Analysis From Bangladesh

Documenti analoghi

• Results From a Phase 1 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ANX005, a C1q Inhibitor, in Patients With Guillain–Barré Syndrome
  di: Quazi Deen Mohammad, et al.
  Pubblicazione: (2025)
• Intravenous Immunoglobulin Elevates Regulatory T Cells in Guillain‐Barré Syndrome: A Potential Biomarker of Therapeutic Response
  di: Israt Jahan, et al.
  Pubblicazione: (2025)
• Patient‐Reported Outcome Measures for Assessing Health‐Related Quality of Life in Patients With Polyneuropathies, Focusing on Guillain‐Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy: A Systematic Review of Measurement Properties
  di: Farah Pelouto, et al.
  Pubblicazione: (2025)
• Altered Cellular Pathways in the Blood of Patients With Guillain‐Barre Syndrome
  di: Marília Fabiana de Oliveira Lima, et al.
  Pubblicazione: (2025)
• Neurological Performance and Clinical Outcomes Related to Patients With Oropouche‐Associated Guillain–Barré Syndrome
  di: Frank D. Martos‐Benítez, et al.
  Pubblicazione: (2025)